Publications by authors named "Rolf Kramer"

Regarding nirsevimab immunization status, among 1085 infants hospitalized for bronchiolitis, the odds of hospitalization for respiratory syncytial virus bronchiolitis were 4.7 times higher for nonimmunized children. Immunized infants were less likely to require oxygen supplementation (20.

View Article and Find Full Text PDF

Background: Respiratory syncytial virus (RSV) and influenza virus are major viral etiologies of pediatric lower respiratory tract infection, but comparative data on inpatient burden are lacking.

Methods: Using a large-scale health claims database in Japan, we identified patients under 5 years of age with a confirmed RSV or influenza diagnosis as an outpatient or inpatient between 2011 and 2022. Hospitalization rate, inpatient characteristics, various in-hospital outcomes/complications, and healthcare resource utilization were described.

View Article and Find Full Text PDF

Introduction: Influenza-associated excess mortality and morbidity is commonly estimated using statistical methods. In Germany, the Robert Koch Institute (RKI) uses the relative mortality distribution method (RMDM) to estimate influenza-associated excess mortality without reporting age-specific values. In order to better differentiate the distribution of the disease burden, a distinction by age is of high relevance.

View Article and Find Full Text PDF

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection (LRTI) in infants and young children worldwide. Using routine statutory health insurance claims data including patients from all regions of Germany, we investigated the health-care resource use and costs associated with RSV prophylaxis with palivizumab in Germany. In the database, infants from the birth cohorts 2015-2019 eligible for palivizumab immunization were identified using codes of the 10 revision of the International Classification of Diseases (ICD-10).

View Article and Find Full Text PDF

Respiratory syncytial virus (RSV) is the most common cause of acute respiratory infections in young children. Limited data are available on RSV disease burden in primary care and emergency departments (EDs). This review synthesizes the evidence on population-based incidence rates of RSV infections in young children (< 5 years) in primary care and EDs.

View Article and Find Full Text PDF

Objective: To assess the burden of respiratory syncytial virus (RSV)-related bronchiolitis in primary care and at 15 days and 6 months after a primary care visit.

Study Design: In this test-negative study, children <2 years old with a first episode of bronchiolitis were prospectively enrolled by 45 ambulatory pediatricians in France from February 2021 to April 2023. RSV was assessed with a rapid antigen detection test.

View Article and Find Full Text PDF
Article Synopsis
  • Nirsevimab has been approved for universal RSV prevention in infants, with a study (NIRSE-GAL) launched in Galicia in September 2023 to assess its effectiveness against various RSV-related health issues.
  • The study will monitor infants during the RSV season, focusing on different groups including newborns and those at high risk, and will track outcomes until significant events occur or the study concludes.
  • Data analysis will utilize sophisticated models and will include safety monitoring of nirsevimab, with results communicated through scientific publications and conferences.
View Article and Find Full Text PDF
Article Synopsis
  • Galicia, Spain, launched a program in September 2023 to give nirsevimab for RSV prevention in infants, focusing on newborns, those under 6 months, and high-risk children aged 6-24 months.
  • The interim analysis of the study, using data from Sept 25 to Dec 31, 2023, assesses nirsevimab's effectiveness in preventing different levels of RSV-related hospitalizations and complications.
  • The study compares the results with data from previous RSV seasons to calculate how many cases of hospitalization were potentially avoided due to the immunization campaign.
View Article and Find Full Text PDF

Objectives: We aimed to study whether the percentwise age distribution of RSV cases changes over time during annual epidemics.

Methods: We used surveillance data (2008-2019) from the Netherlands, Lyon (France), Portugal, Singapore, Ecuador, South Africa, and New Zealand. In each country, every season was divided into "epidemic quarters", i.

View Article and Find Full Text PDF

Background: Respiratory syncytial virus (RSV) causes respiratory tract disease in seasonal waves, primarily in infants and young children. This study aims to quantify the number of RSV-related hospitalizations in children ≤2 years of age and to determine corresponding resource use and costs in Germany.

Methods: We retrospectively analyzed population-wide hospital data from the Institute for the Hospital Remuneration System (InEK) from 2019 to 2022.

View Article and Find Full Text PDF

We aimed to estimate the respiratory syncytial virus positivity rate among ambulatory children with bronchiolitis according to the bronchiolitis epidemic period as defined by the French Public Health Institute. The positivity rate was 28.9% during the nonepidemic period and 50.

View Article and Find Full Text PDF
Article Synopsis
  • Monitoring the real-life effectiveness of respiratory syncytial virus (RSV) prevention methods, like monoclonal antibodies and vaccines, is crucial for public health.
  • The study utilizes a generic protocol for a test-negative design, which can be adapted to various settings to assess effectiveness among children, older adults, and pregnant women.
  • Endpoints include severe acute respiratory infection (SARI) and acute respiratory infection (ARI) related to RSV, applicable in both hospital settings for severe cases and general practitioner clinics for ARI patients.
View Article and Find Full Text PDF
Article Synopsis
  • Several immunization products for respiratory syncytial virus (RSV) are under development and some have received authorization for use in children, pregnant women, and older adults.
  • Researchers need to monitor the effectiveness of these products over the coming years through postmarketing studies.
  • A generic protocol has been created for register-based cohort studies, allowing researchers to utilize available databases and healthcare registers to evaluate the effectiveness of these RSV immunizations on specific and nonspecific outcomes.
View Article and Find Full Text PDF

Background: The significant annual burden caused by seasonal influenza has led to global calls for increased influenza vaccination coverage rates (VCRs). We aimed to estimate the proportion of the German population at high risk of serious illness from influenza due to chronic conditions and to estimate age-specific VCRs of people with/without chronic conditions.

Methods: Using health insurance claims data covering nine influenza seasons (2010-2019), we assessed up to 7 million insured individuals per season across all German regions.

View Article and Find Full Text PDF

Resistance of Aspergillus fumigatus to triazoles has been reported increasingly in Europe. As few data are available from Southern France, the objectives of this study were to assess the burden of A. fumigatus isolates with azole resistance from clinical specimens in Lyon, and explore the resistance mechanisms involved.

View Article and Find Full Text PDF

Annually, increasing numbers of OXA-244-producing in 13 German federal states prompted us to initiate an outbreak investigation. Whole genome sequencing revealed that among 148 isolates analysed, most belonged to sequence type 38 with 62 isolates forming a genetically distinct cluster. Although no epidemiological link could be identified between cases, ongoing investigations suggest non-healthcare associated transmission.

View Article and Find Full Text PDF

From June to October 2019, 17 patients (six infected, 11 colonised) with an extensively drug-resistant (XDR) strain were notified from four Western Pomerania medical facilities. The XDR produced carbapenemases NDM-1 and OXA-48, and was only susceptible to chloramphenicol, tigecycline and cefiderocol. Synergistic activity was observed for the combination of aztreonam plus ceftazidime-avibactam.

View Article and Find Full Text PDF

Acute flaccid myelitis (AFM) was increasingly detected in recent years, coinciding with upsurges of enterovirus D68 (EV-D68) infections. We reviewed the evidence for a causal relationship between both. Based on reported cases, we provide case definitions for AFM caused by EV-D68 infections to enable a standard procedure for affected patients.

View Article and Find Full Text PDF

Objectives: We aimed to describe direct medical costs of annual RSV-associated hospitalisation in the first year of life.

Methods: Retrospective cohort study in Lyon, France (2012-2016). A case was defined as a laboratory confirmed RSV-infection with hospitalisation in the first year of life.

View Article and Find Full Text PDF

BackgroundUnderstanding enterovirus D68 (EV-D68) circulation patterns as well as risk factors for severe respiratory and neurological illness is important for developing preventive strategies. : Between 2010 and 2016, 11,132 respiratory specimens from hospitalised patients in Lyon, France, were screened for EV-D68 by PCR. Phylogenetic relationships of the viral-protein-1 sequences were reconstructed using maximum-likelihood and Bayesian-Markov-Chain-Monte-Carlo approaches.

View Article and Find Full Text PDF
Article Synopsis
  • c-di-GMP is a key second messenger in bacteria that controls critical functions like biofilm formation and virulence, making it a prime target for combating infections.
  • Researchers identified a specific tetrapeptide, Gup-Gup-Nap-Arg, that selectively binds to c-di-GMP in water through screening of a combinatorial peptide library.
  • Further studies revealed that this tetrapeptide effectively inhibits biofilm growth in the pathogen P. aeruginosa and led to the design of a stronger-binding pentapeptide.
View Article and Find Full Text PDF

The aim of this study was to evaluate the potential transmission of HCV strains between HIV-positive men who have sex with men (MSM) and HIV-negative MSM. Since 2000, an ongoing epidemic of HCV infections is observed among HIV-positive MSM in high-income countries. However, HCV infections in HIV-negative MSM are investigated to a lesser extent due to the lack of follow-up in this population and only limited information is available on the risk of HCV transmission between HIV-positive MSM and HIV-negative MSM.

View Article and Find Full Text PDF

Background: The Antarctic continent is considered the coldest and driest place on earth with simple ecosystems, devoid of higher plants. Soils in the ice-free regions of Antarctica are known to harbor a wide range of microorganisms from primary producers to grazers, yet their ecology and particularly the role of viruses is poorly understood. In this study, we examined the virus community structures of 14 soil samples from the Mackay Glacier region.

View Article and Find Full Text PDF